FEDERAL · 15 U.S.C. · Chapter 2

Additional definitions

Current through Pub. L. 119-102
Title 15Commerce and Trade·Ch. 2 — FEDERAL TRADE COMMISSION; PROMOTION OF EXPORT TRADE AND PREVENTION OF UNFAIR METHODS OF COMPETITION·Subch. I

For the purposes of sections 52 to 54 of this title—

(a)False advertisement
(1)The term "false advertisement" means an advertisement, other than labeling, which is misleading in a material respect; and in determining whether any advertisement is misleading, there shall be taken into account (among other things) not only representations made or suggested by statement, word, design, device, sound, or any combination thereof, but also the extent to which the advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the commodity to which the advertisement relates under the conditions prescribed in said advertisement, or under such conditions as are customary or usual. No advertisement of a drug

Free access — add to your briefcase to read the full text and ask questions with AI

15 U.S.C. § 55 (Additional definitions) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Kordel v. United States
335 U.S. 345 (Supreme Court, 1948)
200 case citations
Gladys G. Holloway v. Bristol-Myers Corporation
485 F.2d 986 (D.C. Circuit, 1973)
166 case citations
Federal Trade Commission v. Direct Marketing Concepts, Inc.
624 F.3d 1 (First Circuit, 2010)
81 case citations
Simeon Management Corporation v. Federal Trade Commission
579 F.2d 1137 (Ninth Circuit, 1978)
48 case citations
E. F. Drew & Co., Inc. v. Federal Trade Commission
235 F.2d 735 (Second Circuit, 1956)
44 case citations
Federal Trade Commission v. Simeon Management Corporation
532 F.2d 708 (Ninth Circuit, 1976)
30 case citations
United States v. an Article of Drug Consisting of 250 Jars
218 F. Supp. 208 (E.D. Michigan, 1963)
30 case citations
Pom Wonderful, LLC v. Federal Trade Commission
777 F.3d 478 (D.C. Circuit, 2015)
30 case citations
Federal Trade Commission v. QT, Inc.
448 F. Supp. 2d 908 (N.D. Illinois, 2006)
29 case citations
Rhodes Pharmacal Co., Inc. v. Federal Trade Commission
208 F.2d 382 (Seventh Circuit, 1954)
28 case citations
Dolcin Corp. v. Federal Trade Commission
219 F.2d 742 (D.C. Circuit, 1955)
28 case citations
In Re" Agent Orange" Product Liability Litigation
475 F. Supp. 928 (E.D. New York, 1979)
26 case citations
United States v. JB Williams Company, Inc.
354 F. Supp. 521 (S.D. New York, 1973)
25 case citations
Federal Trade Commission v. National Commission on Egg Nutrition
517 F.2d 485 (Seventh Circuit, 1975)
21 case citations
Fed. Trade Comm'n v. Roca Labs, Inc.
345 F. Supp. 3d 1375 (M.D. Florida, 2018)
10 case citations

Source Credit

History

(Sept. 26, 1914, ch. 311, §15, as added Mar. 21, 1938, ch. 49, §4, 52 Stat. 114; amended Mar. 16, 1950, ch. 61, §4(a), (b), 64 Stat. 21; Pub. L. 94–295, §3(a)(1)(B), May 28, 1976, 90 Stat. 575.)

Editorial Notes

Editorial Notes

Amendments
1976—Subsec. (d). Pub. L. 94–295 expanded definition of "device" to include implements, machines, implants, in vitro reagents, and other similar or related articles, added recognition in the National Formulary or the United States Pharmacopeia, or any supplement to the Formulary or Pharmacopeia, to the enumeration of conditions under which a device may qualify for inclusion under this chapter, and inserted requirements that a device be one which does not achieve any of its principal intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its principal intended purposes.
1950—Subsec. (a). Act Mar. 16, 1950, §4(a), designated existing provisions as par. (1) and added par. (2) relating to oleomargarine.
Subsec. (f). Act Mar. 16, 1950, §4(b), added subsec. (f).

Statutory Notes and Related Subsidiaries

Effective Date of 1950 Amendment
Amendment by act Mar. 16, 1950, effective July 1, 1950, see note set out under section 347 of Title 21, Food and Drugs.